Search research articles
Contact Us
Filters
Showing results (51-60 of 80) with videos related to
Page
of 8
Sort By:
Gynecologic Oncology
|
February 1, 1995
Extramammary Paget's disease of the vulva
D A Fishman, S K Chambers, P E Schwartz, et al.
Cancer
|
December 15, 1989
Development of leukemia after doxorubicin and cisplatin treatment for ovarian cancer
S K Chambers, R L Chopyk, J T Chambers, et al.
Gynecologic Oncology
|
July 1, 1990
Urinary gonadotropin fragment, a new tumor marker. III. Use in cervical and vulvar cancers
J H Nam, K C Chang, J T Chambers, et al.
Gynecologic Oncology
|
September 1, 1988
Estrogen and progestin receptor levels as prognosticators for survival in endometrial cancer
J T Chambers, N MacLusky, A Eisenfield, et al.
Cancer
|
August 1, 1987
Circulating tumor markers in the monitoring of gynecologic malignancies
P E Schwartz, S K Chambers, J T Chambers, et al.
Gynecologic Oncology
|
March 1, 1989
Bleomycin, vincristine, mitomycin C, and cis-platinum in gynecologic squamous cell carcinomas: a high incidence of pulmonary toxicity
S K Chambers, S D Flynn, S A Del Prete, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
March 27, 2003
A pilot study of topotecan in the treatment of serous carcinoma of the uterus
J T Chambers, T J Rutherford, P E Schwartz, et al.
Gynecologic Oncology
|
March 1, 1995
A phase II study of etoposide, cisplatin, and doxorubicin chemotherapy in mixed müllerian tumors (MMT) of the uterus
E Resnik, S K Chambers, M L Carcangiu, et al.
Gynecologic Oncology
|
February 1, 1986
Adjuvant therapy in mixed mullerian tumors of the uterus
E I Kohorn, P E Schwartz, J T Chambers, et al.
Gynecologic Oncology
|
June 15, 1999
Adenocarcinoma in situ of the cervix: management and outcome
M Azodi, S K Chambers, T J Rutherford, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 80) with videos related to
Sort By:
Page
of 8
Gynecologic Oncology
|
February 1, 1995
Extramammary Paget's disease of the vulva
D A Fishman, S K Chambers, P E Schwartz, et al.
Cancer
|
December 15, 1989
Development of leukemia after doxorubicin and cisplatin treatment for ovarian cancer
S K Chambers, R L Chopyk, J T Chambers, et al.
Gynecologic Oncology
|
July 1, 1990
Urinary gonadotropin fragment, a new tumor marker. III. Use in cervical and vulvar cancers
J H Nam, K C Chang, J T Chambers, et al.
Gynecologic Oncology
|
September 1, 1988
Estrogen and progestin receptor levels as prognosticators for survival in endometrial cancer
J T Chambers, N MacLusky, A Eisenfield, et al.
Cancer
|
August 1, 1987
Circulating tumor markers in the monitoring of gynecologic malignancies
P E Schwartz, S K Chambers, J T Chambers, et al.
Gynecologic Oncology
|
March 1, 1989
Bleomycin, vincristine, mitomycin C, and cis-platinum in gynecologic squamous cell carcinomas: a high incidence of pulmonary toxicity
S K Chambers, S D Flynn, S A Del Prete, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
March 27, 2003
A pilot study of topotecan in the treatment of serous carcinoma of the uterus
J T Chambers, T J Rutherford, P E Schwartz, et al.
Gynecologic Oncology
|
March 1, 1995
A phase II study of etoposide, cisplatin, and doxorubicin chemotherapy in mixed müllerian tumors (MMT) of the uterus
E Resnik, S K Chambers, M L Carcangiu, et al.
Gynecologic Oncology
|
February 1, 1986
Adjuvant therapy in mixed mullerian tumors of the uterus
E I Kohorn, P E Schwartz, J T Chambers, et al.
Gynecologic Oncology
|
June 15, 1999
Adenocarcinoma in situ of the cervix: management and outcome
M Azodi, S K Chambers, T J Rutherford, et al.
Page
of 8